F. Hoffmann-La Roche AG

Switzerland

1 September 2020 - 31 August 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for F. Hoffmann-La Roche AG published between 1 September 2020 - 31 August 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
122 44.75

Outputs by subject (Share)

Subject Count Share
Chemistry 23 10.32
Life Sciences 102 36.45
1 0.36
3 1.48
3 0.83
7 1.93
1 0.07
1 0.07
1 1
2 1.31
4 1.21
A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment
2021-04-05
0.97
A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS
2021-02-01
0.04
AKT-dependent NOTCH3 activation drives tumor progression in a model of mesenchymal colorectal cancer
2020-10-05
0.05
Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers
2020-10-05
0.15
1 0.04
10 5.35
1 0.07
29 10.96
5 1.27
3 0.13
2 0.59
2 1.92
1 0.11
2 0.13
8 3.62
1 0.03
7 1.98
2 0.09
5 1.90
Physical Sciences 4 1.82

1 September 2020 - 31 August 2021

International vs. domestic collaboration by Share

  • 7.69% Domestic
  • 92.31% International

Note: Hover over the graph to view the percentage of collaboration.

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Return to institution outputs